Oral Nucleos(t)ide Analog Therapy Alone for Chronic Hepatitis B Patients with Lamivudine-Resistance at Time of Liver Transplantation

被引：0
|
作者：
Fung, James Y. [1 ,2 ,3 ]
Kwan, Man [1 ]
Wong, Tiffany [1 ]
Chok, Kenneth [1 ]
Chan, Albert [1 ]
Cheung, Tan-to [1 ]
Dai, Wing-chiu [1 ]
Sharr, William [1 ]
Sin, Sui-ling [1 ]
Yuen, Man-fung [2 ,3 ]
Lai, Ching-lung [2 ,3 ]
Chan, See-ching [1 ,3 ]
Lo, Chung-mau [1 ,3 ]
机构：
[1] Univ Hong Kong, Surg, Hong Kong, Hong Kong, Peoples R China
[2] Univ Hong Kong, Med, Hong Kong, Hong Kong, Peoples R China
[3] Univ Hong Kong, State Key Lab Liver Res, Hong Kong, Hong Kong, Peoples R China
来源：
TRANSPLANTATION | 2016年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
O-35
引用
收藏
页码：S91 / S91
页数：1
相关论文
共 50 条
  • [21] Benefit of stopping finite nucleos(t)ide analogues therapy in chronic hepatitis B patients
    Liaw, Yun-Fan
    Jeng, Wen-Juei
    GUT, 2020, 69 (10) : 1898 - 1899
  • [22] The efficacy of entecavir therapy in nucleos(t)ide-naive patients with chronic hepatitis B
    Kim, J-W
    Park, N. H.
    Shin, J. W.
    Jung, S. W.
    Oh, S. Y.
    Lee, S. J.
    Lee, J. E.
    Jeong, I. D.
    Bang, S-J
    Kim, D. H.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A189 - A189
  • [23] Outcome of chronic hepatitis B patients who discontinued nucleos(t)ide analogue therapy
    Yapali, Suna
    Oberhelman, Kelly
    Lok, Anna S.
    HEPATOLOGY, 2014, 60 : 1114A - 1115A
  • [24] A case of chronic hepatitis B complicated by systemic sarcoidosis that regressed following nucleos(t)ide analog therapy
    Semba, Shigeaki
    Teraoka, Yuji
    Kamada, Hiroki
    Kato, Naohiro
    Mizumoto, Takeshi
    Tamaru, Yuzuru
    Hatakeyama, Tsuyoshi
    Yamaguchi, Atsushi
    Kouno, Hirotaka
    Yoshida, Shigeto
    CLINICAL JOURNAL OF GASTROENTEROLOGY, 2025,
  • [25] Antiviral therapy with nucleos (t)ide analogues for severe chronic hepatitis B
    Zhang, Fu-Kui
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2009, 8 (04) : 438 - 439
  • [26] Serum O-glycosylated hepatitis B surface antigen levels in patients with chronic hepatitis B during nucleos(t)ide analog therapy
    Ayato Murata
    Kiyohiko Angata
    Maki Sogabe
    Shunsuke Sato
    Takafumi Ichida
    Hisashi Narimatsu
    Takuya Genda
    BMC Gastroenterology, 22
  • [27] Serum O-glycosylated hepatitis B surface antigen levels in patients with chronic hepatitis B during nucleos(t)ide analog therapy
    Murata, Ayato
    Angata, Kiyohiko
    Sogabe, Maki
    Sato, Shunsuke
    Ichida, Takafumi
    Narimatsu, Hisashi
    Genda, Takuya
    BMC GASTROENTEROLOGY, 2022, 22 (01)
  • [28] Antiviral therapy with nucleos(t)ide analogues for severe chronic hepatitis B
    Fu-Kui Zhang
    Hepatobiliary&PancreaticDiseasesInternational, 2009, 8 (04) : 438 - 439
  • [29] Cost-effectiveness comparison of lamivudine plus adefovir combination treatment and nucleos(t)ide analog monotherapies in Chinese chronic hepatitis B patients
    Zhang, Chi
    Ke, Weixia
    Liu, Li
    Gao, Yanhui
    Yao, Zhenjiang
    Ye, Xiaohua
    Zhou, Shudong
    Yang, Yi
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 : 897 - 910
  • [30] Pegylated IFN-α 2b added to added to ongoing lamivudine therapy in patients with lamivudine-resistance chronic hepatitis B
    Vassiliadis, Themistoklis
    Patsiaoura, Kalliopi
    Tziomalos, Konstantinos
    Gkiourtzis, Theodoros
    Giouleme, Olga
    Grammatikos, Nikolaos
    Rizopoulou, Despoina
    Nikolaidis, Nikolaos
    Katsinelos, Panagiotis
    Orfanou-Koumerkeridou, Eleni
    Eugenidis, Nikolaos
    WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (15) : 2417 - 2422
12345